Securities code: 002326 securities abbreviation: Zhejiang Yongtai Technology Co .Ltd(002326) Announcement No.: 2022-002 Zhejiang Yongtai Technology Co .Ltd(002326)
About the reduction of Jiangxi Fushine Pharmaceutical Co.Ltd(300497) shares held by the company
Progress announcement
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Zhejiang Yongtai Technology Co .Ltd(002326) (hereinafter referred to as “the company”) disclosed the announcement on the proposed reduction of Jiangxi Fushine Pharmaceutical Co.Ltd(300497) shares held by the company (Announcement No.: 2021-088) on cninfo.com on December 4, 2021. Within six months after three trading days from the date of announcement, the reduction plan will be carried out through centralized bidding and block trading in accordance with relevant laws and regulations, According to the situation of the securities market, no more than 58356100 Jiangxi Fushine Pharmaceutical Co.Ltd(300497) shares shall be sold at the right time (if there are share changes such as share bonus and conversion of capital reserve to share capital during this period, the number shall be adjusted accordingly).
1、 Implementation progress of share reduction plan
Up to now, the number of Jiangxi Fushine Pharmaceutical Co.Ltd(300497) shares held by the company has been reduced by more than half. According to the relevant provisions of Several Provisions on the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies and the implementation rules for the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies on Shenzhen Stock Exchange, the implementation progress of the reduction of Jiangxi Fushine Pharmaceutical Co.Ltd(300497) shares held by the company is hereby announced as follows:
Reduction date reduction method reduction number of shares (shares) reduction amount (yuan) reduction proportion (%)
2022-01-13 2,908,591 53,033,284.14 0.54%
Centralized bidding method
2022-01-19 2,507,040 53,390,030.40 0.46%
Total – 5415631 106423314.54 1.00%
The above shares are derived from the shares before Jiangxi Fushine Pharmaceutical Co.Ltd(300497) initial public offering and the shares increased accordingly due to equity distribution. After the sale of the above shares, the company still holds 419979 shares of Jiangxi Fushine Pharmaceutical Co.Ltd(300497) shares, accounting for 0.08% of the total share capital after excluding the shares in the special account for Jiangxi Fushine Pharmaceutical Co.Ltd(300497) repurchase.
2、 Other relevant instructions
As of the date of this announcement, the company’s reduction of Jiangxi Fushine Pharmaceutical Co.Ltd(300497) shares was within the reduction plan and complied with the provisions of relevant laws, regulations and normative documents such as the securities law, several provisions on the reduction of shares by shareholders, directors, supervisors and senior managers of listed companies, detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of listed companies on Shenzhen Stock Exchange, and there were no violations.
It is hereby announced.
Zhejiang Yongtai Technology Co .Ltd(002326) board of directors January 20, 2022
